ACADIAN ASSET MANAGEMENT LLC

Position in TNYA — Tenaya Therapeutics, Inc.

CIK 916542 Boston, MA

Position in TNYA

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$117,487

+$100,289 QoQ

Shares Held

169,780

+462.7% QoQ

Ownership

0.078%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#31

of 103 holders

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $659,552,548 across 178 Biotechnology names. TNYA ranks #136 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,900,824	$178,905,554
2	REGN	Regeneron Pharmaceuticals, Inc.	151,191	$116,816,214
3	LEGN	Legend Biotech Corp	1,527,336	$27,629,508
4	TBPH	Theravance Biopharma, Inc.	1,276,576	$20,718,828
5	RIGL	Rigel Pharmaceuticals Inc	666,426	$18,020,159
6	IMCR	Immunocore Holdings plc	501,091	$15,107,893
7	PRTA	Prothena Corp Public Ltd Co	1,547,593	$15,042,603
8	PBYI	Puma Biotechnology, Inc.	2,041,759	$13,046,840

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$117,487	169,780	+462.7%	Shares	Defined	2026-05-13
2025-03-31	$17,198	30,173	+140.2%	Shares	Defined	2025-05-21
2024-09-30	$24,248	12,564	+5.9%	Shares	Defined	2024-11-12
2024-06-30	$36,772	11,862	-93.4%	Shares	Defined	2024-08-06
2024-03-31	$936,860	179,132	-39.2%	Shares	Defined	2024-05-10
2023-12-31	$954,196	294,505	+183.0%	Shares	Defined	2024-02-13
2023-09-30	$265,375	104,069	+501.6%	Shares	Defined	2023-11-13
2023-06-30	$101,551	17,300	-40.2%	Shares	Defined	2023-08-07
2023-03-31	$82,422	28,920	—	Shares	Defined	2023-05-11
No filing history on record for this holder in this stock.